Furthermore, administration of miR-16-1 via a nano-cell delivery system which is an EGFR-targeted Delivery Vehicle (EDV) of EnGeneIC in NSCLC xenograft mice models and malignant pleural mesothelioma, led to the targeted delivery in tumor and considerable tumor repression [39]. Here, EGFR is linked to non-small cell lung carcinoma.